These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 19852527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
    Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F.
    N Engl J Med; 2008 Dec 04; 359(23):2442-55. PubMed ID: 19052126
    [Abstract] [Full Text] [Related]

  • 3. Tenofovir disoproxil fumarate for the treatment of hepatitis B infection.
    Adusumilli S.
    Drugs Today (Barc); 2009 Sep 04; 45(9):679-85. PubMed ID: 19956809
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection.
    Jones J, Colquitt J, Shepherd J, Harris P, Cooper K.
    Health Technol Assess; 2010 May 04; 14 Suppl 1():23-9. PubMed ID: 20507800
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients.
    Yang DH, Xie YJ, Zhao NF, Pan HY, Li MW, Huang HJ.
    World J Gastroenterol; 2015 Mar 07; 21(9):2746-53. PubMed ID: 25759545
    [Abstract] [Full Text] [Related]

  • 9. Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B.
    Patterson SJ, George J, Strasser SI, Lee AU, Sievert W, Nicoll AJ, Desmond PV, Roberts SK, Locarnini S, Bowden S, Angus PW.
    Gut; 2011 Feb 07; 60(2):247-54. PubMed ID: 21036792
    [Abstract] [Full Text] [Related]

  • 10. Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B.
    Tsai NC, Marcellin P, Buti M, Washington MK, Lee SS, Chan S, Trinh H, Flaherty JF, Kitrinos KM, Dinh P, Charuworn P, Subramanian GM, Gane E.
    Dig Dis Sci; 2015 Jan 07; 60(1):260-8. PubMed ID: 25179493
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.
    Heathcote EJ, Marcellin P, Buti M, Gane E, De Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Gurel S, Snow-Lampart A, Borroto-Esoda K, Mondou E, Anderson J, Sorbel J, Rousseau F.
    Gastroenterology; 2011 Jan 07; 140(1):132-43. PubMed ID: 20955704
    [Abstract] [Full Text] [Related]

  • 14. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.
    Buti M, Gane E, Seto WK, Chan HL, Chuang WL, Stepanova T, Hui AJ, Lim YS, Mehta R, Janssen HL, Acharya SK, Flaherty JF, Massetto B, Cathcart AL, Kim K, Gaggar A, Subramanian GM, McHutchison JG, Pan CQ, Brunetto M, Izumi N, Marcellin P, GS-US-320-0108 Investigators.
    Lancet Gastroenterol Hepatol; 2016 Nov 07; 1(3):196-206. PubMed ID: 28404092
    [Abstract] [Full Text] [Related]

  • 15. Tenofovir disoproxil fumarate for the treatment of HIV infection.
    Pham PA, Gallant JE.
    Expert Opin Drug Metab Toxicol; 2006 Jun 07; 2(3):459-69. PubMed ID: 16863446
    [Abstract] [Full Text] [Related]

  • 16. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
    Fung S, Kwan P, Fabri M, Horban A, Pelemis M, Hann HW, Gurel S, Caruntu FA, Flaherty JF, Massetto B, Dinh P, Corsa A, Subramanian GM, McHutchison JG, Husa P, Gane E.
    Gastroenterology; 2014 Apr 07; 146(4):980-8. PubMed ID: 24368224
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection.
    Marcellin P, Wong DK, Sievert W, Buggisch P, Petersen J, Flisiak R, Manns M, Kaita K, Krastev Z, Lee SS, Cathcart AL, Crans G, Op den Brouw M, Jump B, Gaggar A, Flaherty J, Buti M.
    Liver Int; 2019 Oct 07; 39(10):1868-1875. PubMed ID: 31136052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.